http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2255202-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_523523e4857f980c860a0d49e77ed0ec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_457aac9ad18e13cc44a15d1cfaa62b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78a76a59a401c68d802b485eb898135e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75a627d71240157fb70433586e90f471
publicationDate 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2255202-B1
titleOfInvention Use of procalcitonin (pct) in prognosis following acute coronary syndromes
priorityDate 2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135460965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57079521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403922

Total number of triples: 22.